Cutaneous metastasis from cervical cancer to the scalp and trunk: a case report and review of the literature

Background An estimated 119,300 new cases of cervical cancer occur annually in China, accounting for 372,00 deaths.

Cutaneous metastasis from cervical cancer is a rare event, with an incidence of 0.1–1.3% and typically a preterminal occurrence.

Scalp metastasis from cervical cancer is exceptionally anecdotal, with only a dozen examples well documented.

Case presentation The patient is a 33-year-old Chinese woman who was diagnosed with International Federation of Gynecology and Obstetrics stage IVB cervical cancer in November 2021.

From December 2021 to April 2022, the patient was enrolled in the clinical trial of sintilimab combined with chemotherapy and radiotherapy for treatment of stage IV cervical cancer and underwent six cycles of immunotherapy and chemotherapy (sintilimab plus paclitaxel liposome and cisplatin).

Treatment was well tolerated and led to a partial response.

The masses adjacent to the spine and iliac bone was largely reduced.

Thus, radiotherapy of the metastatic residues was carried out and followed by radiotherapy to the primary tumor at the cervix uteri.

However, by the time of the radiotherapy completion in October 2022, the patient noticed painless nodules at the left scapular region and the right hypochondrium.

The following month, more nodules occurred on the scalp and trunk, including the left axilla, anterior abdomen, and left back, along with a lesion invading the sternum that caused acute bone pain.

The cutaneous masses were white, discrete with a rubbery consistency, and fixed to the skin.

Several nodules increased in size and eventually ulcerated.

Fine‑needle aspiration cytology of the left back swellings revealed metastatic squamous cell carcinoma, P16 positive.

No visceral or brain metastasis was observed at this point.

Conclusions Cervical cancer metastases to the scalp are extremely uncommon.

When a scalp metastasis is present, it might be the only symptomatic sign of disease progression or widespread metastatic lesions.

So far, there is no clear guideline regarding skin metastases treatment.

Such skin lesions warrant a thorough radiologic and pathologic workup to form a comprehensive management plan.